FIELD: pharmacology.
SUBSTANCE: invention is a haemostatic sponge containing a base and an active substance, freeze-dried. According to the invention, the sponge, contains chitosan in acetic acid as the base and a fibrin monomer as the active substance, the components in the spongeare at a certain ratio in % by 1 litre volume.
EFFECT: expansion of haemostatic sponges assortment based on a chitosan and fibrin-monomer complex with pronounced haemostatic action.
4 cl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
HEMOSTATIC SOLUTION BASED ON SULFUSATED POLYSACCHARIDES AND THE HEMOSTATIC SPONGES PRODUCTION FROM THIS SOLUTION (OPTIONS) | 2017 |
|
RU2652270C1 |
HEMOSTATIC SPONGE (VERSIONS) | 2016 |
|
RU2627855C1 |
HEMOSTATIC SPONGE AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2628809C1 |
HEMOSTATIC COATING IN FORM OF SPONGE OR FILM (VERSIONS) | 2016 |
|
RU2639379C1 |
HAEMOSTATIC AGENT BASED ON POLYVINYLPYRROLIDONE AND METHODS FOR PREPARING ITS PHARMACOLOGICAL FORMS | 2018 |
|
RU2705812C1 |
WOUND COVER WITH HEMOSTATIC ACTION, AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2624242C1 |
HEMOSTATIC COATING IN THE FORM OF POWDER | 2017 |
|
RU2660582C1 |
HAEMOSTATIC POLYMER-BASED AGENT CONTAINING MICROPARTICLES AND IRON OXIDE NANOPARTICLES, AND METHODS FOR PREPARING PHARMACOLOGICAL FORMS THEREOF | 2020 |
|
RU2739490C1 |
HEMOSTATIC SPONGE | 1996 |
|
RU2122867C1 |
HAEMOSTATIC AGENT | 2004 |
|
RU2275201C2 |
Authors
Dates
2017-05-11—Published
2016-06-30—Filed